Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 12
Submit an article Journal homepage
4,667
Views
21
CrossRef citations to date
0
Altmetric
Short Report

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

Lidia Oostvogelsa GSK, Wavre, BelgiumORCID Iconhttps://orcid.org/0000-0003-1298-0360View further author information
ORCID Icon,
Thomas C. Heinemanb GSK, King of Prussia, PA, USAORCID Iconhttps://orcid.org/0000-0003-4500-5676View further author information
ORCID Icon,
Robert W. Johnsonc Faculty of Health Sciences, University of Bristol, Bristol, UKORCID Iconhttps://orcid.org/0000-0002-8376-7412View further author information
ORCID Icon,
Myron J. Levind Departments of Pediatrics and Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USAORCID Iconhttps://orcid.org/0000-0002-7468-106XView further author information
ORCID Icon,
Janet E. McElhaneye Health Sciences North Research Institute, Sudbury, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0002-0690-1446View further author information
ORCID Icon,
Peter Van den Steena GSK, Wavre, BelgiumCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7931-1781View further author information
ORCID Icon,
Toufik Zahafa GSK, Wavre, BelgiumORCID Iconhttps://orcid.org/0000-0002-2049-5210View further author information
ORCID Icon,
Alemnew F. Dagnewf GSK, Rockville, MD, USAORCID Iconhttps://orcid.org/0000-0003-4181-058XView further author information
ORCID Icon,
Roman Chlibekg Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech RepublicORCID Iconhttps://orcid.org/0000-0002-7387-3844View further author information
ORCID Icon,
Javier Diez-Domingoh Fundación para el Fomento de la Investigación Sanitaria y Biomédica, Valencia, SpainORCID Iconhttps://orcid.org/0000-0003-1008-3922View further author information
ORCID Icon,
Iris S. Gorfinkeli PrimeHealth Clinical Research, Toronto, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0002-8812-941XView further author information
ORCID Icon,
Caroline Hervéa GSK, Wavre, BelgiumORCID Iconhttps://orcid.org/0000-0002-0794-8748View further author information
ORCID Icon,
Shinn-Jang Hwangj Department of Family Medicine, Taipei Veterans General Hospital and National Yang Ming University School of Medicine, Taipei, TaiwanORCID Iconhttps://orcid.org/0000-0003-3217-6193View further author information
ORCID Icon,
Hideyuki Ikematsuk Japan Physicians Association, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-3548-4231View further author information
ORCID Icon,
George Kalemal Keyrus Biopharma, Waterloo, Belgium, on behalf of GSKORCID Iconhttps://orcid.org/0000-0002-0535-5930View further author information
ORCID Icon,
Himal Lalb GSK, King of Prussia, PA, USAORCID Iconhttps://orcid.org/0000-0001-7174-1314View further author information
ORCID Icon,
Shelly A. McNeilm Canadian Center for Vaccinology, IWK Health Center and Nova Scotia Health Authority, Dalhousie, University, Halifax, CanadaORCID Iconhttps://orcid.org/0000-0001-5444-4166View further author information
ORCID Icon,
Tomas Mrkvana GSK, Wavre, BelgiumView further author information
,
Karlis Pauksensn Department of Infectious Diseases, Uppsala University Hospital, Uppsala, SwedenORCID Iconhttps://orcid.org/0000-0003-2626-7574View further author information
ORCID Icon,
Jan Smetanag Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech RepublicORCID Iconhttps://orcid.org/0000-0002-3770-1754View further author information
ORCID Icon,
Daisuke Watanabeo Department of Dermatology, Aichi Medical University, Nagakute, JapanORCID Iconhttps://orcid.org/0000-0001-6817-3993View further author information
ORCID Icon,
Lily Yin Weckxp Department of Pediatrics, Federal University of Sao Paulo, Sao Paulo, BrazilORCID Iconhttps://orcid.org/0000-0003-4949-3582View further author information
ORCID Icon &
Anthony L. Cunninghamq The Westmead Institute for Medical Research, Westmead, University of Sydney, Sydney, NSW, AustraliaORCID Iconhttps://orcid.org/0000-0002-6744-5667View further author information
ORCID Icon show all
Pages 2865-2872 | Received 15 Feb 2019, Accepted 27 May 2019, Published online: 28 Jun 2019

References

  • Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81:928–30. doi:10.1212/WNL.0b013e3182a3516e.
  • Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833. doi:10.1136/bmjopen-2014-004833.
  • Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clinic Proc. 2017;92:1806–21. doi:10.1016/j.mayocp.2017.10.009.
  • Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM. Quantification of risk factors for herpes zoster: population based case-control study. Bmj. 2014;348:g2911. doi:10.1136/bmj.g2911.
  • Hata A, Kuniyoshi M, Ohkusa Y. Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection. 2011;39:537–44. doi:10.1007/s15010-011-0162-0.
  • Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271–84. doi:10.1056/NEJMoa051016.
  • Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barberà J, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372:2087–96. doi:10.1056/NEJMoa1501184.
  • Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barberà J, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375:1019–32. doi:10.1056/NEJMoa1603800.
  • Schmader KE, Levin MJ, Gnann JW Jr., McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su S-C, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012;54:922–28. doi:10.1093/cid/cir970.
  • Lecrenier N, Beukelaers P, Colindres R, Curran D, De Kesel C, De Saegher J-P, Didierlaurent AM, Ledent EY, Mols JF, Mrkvan T, et al. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Expert Rev Vaccines. 2018;17:619–34. doi:10.1080/14760584.2018.1495565.
  • Prince MJ, Wu F, Guo Y, Gutierrez Robledo LM, O’Donnell M, Sullivan R, Yusuf S. The burden of disease in older people and implications for health policy and practice. Lancet. 2015;385:549–62. doi:10.1016/S0140-6736(14)61347-7.
  • de la Serna J, Campora L, Chandrasekar P, El Idrissi M, Gaidano G, López Fauqued M, Oostvogels L, Schwartz S, Sullivan K, Szer J, Bastidas A. Efficacy and safety of an adjuvanted herpes zoster subunit vaccine in autologous hematopoietic stem cell transplant recipients 18 years of age or older: first results of the phase 3 randomized, placebo-controlled ZOE-HSCT clinical trial. BMT Tandem Meetings, Salt Lake City, Utah. 2018: abstract LBA2.
  • Dagnew AF, Ilhan O, Lee W-S, Woszczyk D, Kwak J-Y, Bowcock S,  Sohn SK, Rodriguez Macías G, Chiou T-J, Quiel D, et al. Immunogenicity, safety and efficacy assessment of the adjuvanted recombinant zoster vaccine in adults with hematologic malignancies: a phase 3, randomized clinical trial. ID Week. 2018: abstract 140.
  • Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24. doi:10.1186/1471-2318-8-24.
  • Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci World J. 2001;1:323–36. doi:10.1100/tsw.2001.58.
  • Andrew MK, Shinde V, Ye L, Hatchette T, Haguinet F, Dos Santos G, McElhaney JE, Ambrose A, Boivin G, Bowie W, et al. The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people. J Infect Dis. 2017;216:405–14. doi:10.1093/infdis/jix282.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.